a combined chemotherapy of Erlotinib plus Pemetrexed

2 trials

Sponsors

Kochi University, School of Medicine, Department of Hematology and Resporatory Medicine, Toho University Omori Medical Center

Conditions

Non-Small Cell Lung CancerNon-small cell lung cancer

Phase 2

A phase II study of Erlotinib plus Pemetrexed for previously treated Non Small Cell Lung Cancer

Active, not recruitingJPRN-UMIN000007397

Kochi University, School of Medicine, Department of Hematology and Resporatory MedicineNon-Small Cell Lung Cancer

Start: 2012-03-01Target: 27Updated: 2026-06-29

A phase II study of Erlotinib plus Pemetrexed for Non Small Cell Lung Cancer with T790M negative previously treated with EGFR-TKI

RecruitingJPRN-UMIN000008033

Toho University Omori Medical CenterNon-small cell lung cancer

Start: 2012-06-01Target: 15Updated: 2026-06-29